DEXTROSE 4.3 % AND SODIUM CHLORIDE 0.18 % INJECTION

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

GLUCOSE ANHYDROUS; SODIUM CHLORIDE

제공처:

NEOPHARM (ISRAEL) 1996 LTD

ATC 코드:

B05BB01

약제 형태:

SOLUTION FOR INJECTION

구성:

SODIUM CHLORIDE 0.18 G / 100 ML; GLUCOSE ANHYDROUS 4.3 G / 100 ML

관리 경로:

I.V

처방전 유형:

Required

Manufactured by:

NEOPHARM (ISRAEL) LTD - CURE MEDICAL MANUFACTURING PLANT

치료 그룹:

ELECTROLYTES

치료 영역:

ELECTROLYTES

치료 징후:

Supply of water for administration of electrolytes or calories. Vehicle for therapeutic regimen.

승인 날짜:

2011-01-31

제품 특성 요약

NEOPHARM (ISRAEL) LTD. -
INTRAVENOUS INJECTIONS IN PLASTIC CONTAINERS
1. SINGLE ELECTROLYTE SOLUTIONS
1. 0.45% Sodium Chloride Injection.
2. SINGLE ELECTROLYTE SOLUTIONS WITH DEXTROSE
1. 3.3% Dextrose and 0.3% Sodium Chloride Injection.
2. 4.3% Dextrose and 0.18% Sodium Chloride Injection.
3. 5% Dextrose and 0.33% Sodium Chloride Injection.
4. 5% Dextrose and 0.45% Sodium Chloride Injection.
5.
5% Dextrose and 0.9% Sodium Chloride Injection.
3. MULTIPLE ELECTROLYTE SOLUTIONS WITH DEXTROSE
1. 5% Dextrose and 0.3% Sodium Chloride and 0.15% Potassium Chloride
Injection.
DESCRIPTION
Intravenous solutions are sterile, nonpyrogenic and contain no
bacteriostatic or antimicrobial agents or added buffers.
The composition, osmolarity and approx. pH values of the individual
solutions are shown in
Table 1.
ACTIONS
Intravenous solutions provide electrolytes and/or calories, and are a
source of water for hydration. All are capable of
inducing diuresis depending on the clinical condition of the patient.
Solutions containing dextrose provide calories. See
Table 2 for calories per liter of the various solutions.
Solutions which are di-electrolytic or polyelectrolytic have value in
maintaining or replenishing electrolytes. See Table 2
for ionic concentrations.
INDICATIONS

Supply of water, for administration of electrolytes or calories.

Vehicle for therapeutic regimen.
CONTRAINDICATIONS
Excess body water volume.
Diabetic coma with excessively high blood sugar (solutions containing
glucose).
Hypovolaemia.
Cardiac insufficiency.
Edema, ascites ( cirrhosis related syndrome).
WARNINGS
Dispensing without a doctor's prescription is prohibited.
The administration of Intravenous Injections can cause fluid and/or
solute overloading resulting in dilution of serum
electrolyte concentrations, overhydration, congestive conditions, or
pulmonary edema. The risk of serum dilution is
inversely proportional to the electrolyte concentrations of the
injections.
The risk of solute overload causing congestion with peripheral and
pulmonary edema